MacKenzie Scott’s donation to Direct Relief equaled the largest in the organization’s history, at $50 million, and will go toward the Fund for Health Equity, a new project Direct Relief unveiled March 2. Scott announced in December that she was giving nearly $4.2 billion to 384 different charitable organizations in the United States. Direct Relief, Read More →
By Paul D. Witman I was recently diagnosed with Parkinson’s disease, a progressive, slow-moving disease that has no known cure. My father passed away 10 years ago from the same disease, so this diagnosis generated some deep thinking about how I would respond to it. Modern science has identified treatments for many of the symptoms, Read More →
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
Goleta-based Inogen reported declines in both revenue and net income due to the COVID-19 pandemic on Feb. 24, when the maker of portable oxygen concentrators released its financial results for the fourth quarter and full year of 2020. Total revenue for the fourth quarter was $74 million, a decline of 6.3% from the same quarter Read More →
When the state came out from under the last round of stay-at-home orders, Ventura County settled most of its 13 lawsuits against gyms and restaurants that stayed open despite state and local health orders. There are still several active cases open, though, as some businesses continue to defy the orders by holding indoor operations—which are Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Moderna didn’t expect to go to market with its new vaccine technology for several years when 2020 began, the company’s CFO said in a recent talk, but that changed after the technology Moderna spent almost a decade developing helped fast-forward development for COVID-19 vaccines. More than 1,000 people watched a virtual discussion on Feb. 17 Read More →